Rv1908c - p.Thr344Pro
Drug resistance types
2 Sensitive
8 RR-TB
4 HR-TB
4 MDR-TB
2 Pre-XDR-TB
0 XDR-TB
1 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage4.8 | 3 |
| lineage2.2.1 | 5 |
| lineage4.2.1 | 1 |
| lineage3 | 1 |
| lineage1.1.2 | 1 |
| lineage2.2.1;lineage4.9 | 1 |
| lineage4.1.2.1 | 1 |
| lineage4.1.1;lineage4.1.2 | 1 |
| lineage4.4.1.1 | 2 |
| lineage4.3.4.2 | 1 |
| lineage4.3.3 | 1 |
| lineage4.3.4.1 | 2 |
| lineage4.6.1.1 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 21 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Variant Proportion
Hover over a Country 0–0.1
0.1–0.2
0.2–0.3
0.3–0.4
0.4–0.5
0.5–0.6
0.6–0.8
0.8+
0.1–0.2
0.2–0.3
0.3–0.4
0.4–0.5
0.5–0.6
0.6–0.8
0.8+
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 |
|---|---|---|---|
| ERR8774362 | RR-TB | lineage4.8 | None |
| SRR25206901 | MDR-TB | lineage2.2.1 | None |
| ERR13275937 | HR-TB | lineage4.2.1 | None |
| SRR29289406 | Pre-XDR-TB | lineage3 | None |
| ERR4798946 | MDR-TB | lineage1.1.2 | in |
| SRR18593232 | MDR-TB | lineage2.2.1;lineage4.9 | None |
| SRR16100250 | Sensitive | lineage2.2.1 | None |
| ERR11081826 | RR-TB | lineage4.1.2.1 | None |
| SRR28394161 | Other | lineage4.1.1;lineage4.1.2 | None |
| ERR10680051 | RR-TB | lineage4.4.1.1 | None |
| ERR10748370 | RR-TB | lineage2.2.1 | None |
| ERR10680202 | RR-TB | lineage4.8 | None |
| SRR6356960 | RR-TB | lineage4.3.4.2 | None |
| SRR6785201 | RR-TB | lineage2.2.1 | None |
| ERR4813647 | Pre-XDR-TB | lineage4.3.3 | None |
| ERR8774363 | RR-TB | lineage4.8 | None |
| SRR13583407 | HR-TB | lineage4.3.4.1 | None |
| ERR13291752 | Sensitive | lineage2.2.1 | None |
| SRR29050667 | HR-TB | lineage4.3.4.1 | None |
| ERR6358722 | MDR-TB | lineage4.6.1.1 | None |
| SRR21240128 | HR-TB | lineage4.4.1.1 | None |
